Unknown

Dataset Information

0

Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March-May 2020.


ABSTRACT: We report off-label use patterns for medications repurposed for coronavirus disease 2019 (COVID-19) at 318 US hospitals. Inpatient hydroxychloroquine use declined by 80%, whereas corticosteroids and tocilizumab were initiated 2 days earlier in May versus March 2020. Two thirds of ventilated COVID-19 patients were already receiving corticosteroids during March-May 2020, resembling pre-COVID use in mechanically ventilated influenza patients.

SUBMITTER: Kadri SS 

PROVIDER: S-EPMC7798707 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March-May 2020.

Kadri Sameer S SS   Demirkale Cumhur Y CY   Sun Junfeng J   Busch Lindsay M LM   Strich Jeffrey R JR   Rosenthal Ning N   Warner Sarah S  

Open forum infectious diseases 20201215 2


We report off-label use patterns for medications repurposed for coronavirus disease 2019 (COVID-19) at 318 US hospitals. Inpatient hydroxychloroquine use declined by 80%, whereas corticosteroids and tocilizumab were initiated 2 days earlier in May versus March 2020. Two thirds of ventilated COVID-19 patients were already receiving corticosteroids during March-May 2020, resembling pre-COVID use in mechanically ventilated influenza patients. ...[more]

Similar Datasets

| S-EPMC7119513 | biostudies-literature
| S-EPMC7510702 | biostudies-literature
| S-EPMC7147903 | biostudies-literature
| S-EPMC7302472 | biostudies-literature
| S-EPMC7994039 | biostudies-literature
| S-EPMC7943952 | biostudies-literature
| S-EPMC11318085 | biostudies-literature
| S-EPMC7799269 | biostudies-literature
| S-EPMC8507592 | biostudies-literature
| S-EPMC8280389 | biostudies-literature